Publication | Closed Access
SC-54684A: An Orally Active Inhibitor of Platelet Aggregation
65
Citations
29
References
1995
Year
SC-54684A, an orally active antiplatelet drug now in clinical trial, is shown to be a potent, specific fibrinogen binding inhibitor that blocks platelet aggregation to a wide variety of known stimuli and has good bioavailability in animals.
| Year | Citations | |
|---|---|---|
1990 | 1.6K | |
1971 | 1.5K | |
1986 | 934 | |
1979 | 711 | |
1985 | 590 | |
1989 | 554 | |
1988 | 515 | |
1991 | 350 | |
1987 | 263 | |
1987 | 262 |
Page 1
Page 1